RU2013141485A - BIOLOGICALLY ACTIVE PEPTIDES - Google Patents

BIOLOGICALLY ACTIVE PEPTIDES Download PDF

Info

Publication number
RU2013141485A
RU2013141485A RU2013141485/10A RU2013141485A RU2013141485A RU 2013141485 A RU2013141485 A RU 2013141485A RU 2013141485/10 A RU2013141485/10 A RU 2013141485/10A RU 2013141485 A RU2013141485 A RU 2013141485A RU 2013141485 A RU2013141485 A RU 2013141485A
Authority
RU
Russia
Prior art keywords
gly
val
gln
ser
glyhis
Prior art date
Application number
RU2013141485/10A
Other languages
Russian (ru)
Other versions
RU2575069C2 (en
Inventor
Игорь Беккер
Мариола Кучер
Элизабет Чарниевска
Гжегож Розински
Борис Алексеевич Никонов
Су Ин Ким
Original Assignee
Общество с ограниченной ответственностью "Аллоферон"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Аллоферон" filed Critical Общество с ограниченной ответственностью "Аллоферон"
Priority to RU2013141485/10A priority Critical patent/RU2575069C2/en
Priority claimed from RU2013141485/10A external-priority patent/RU2575069C2/en
Priority to EA201401290A priority patent/EA031772B1/en
Publication of RU2013141485A publication Critical patent/RU2013141485A/en
Application granted granted Critical
Publication of RU2575069C2 publication Critical patent/RU2575069C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Биологически активные пептидыHis-Gly-Val-Ser-Gly-Tyr-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Ala-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Arg-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Lys-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Phe-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Phe(p-OMet)-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Phe(p-Cl)-Gly-Gln-His-Gly-Val-His-Gly,обладающие высоким иммуномодулирующем, противовирусным и противораковым действием.2. Фармацевтические композиции, содержащие пептиды по п.1 или их фармацевтически приемлемые соли в сочетании со стандартными вспомогательными веществами.1. Biologically active peptides His-Gly-Val-Ser-Gly-Tyr-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Ala-Gly-Gln-His-Gly-Val- His-GlyHis-Gly-Val-Ser-Gly-Arg-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Lys-Gly-Gln-His-Gly-Val-His- GlyHis-Gly-Val-Ser-Gly-Phe-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Phe (p-OMet) -Gly-Gln-His-Gly-Val -His-GlyHis-Gly-Val-Ser-Gly-Phe (p-Cl) -Gly-Gln-His-Gly-Val-His-Gly, with high immunomodulating, antiviral and anti-cancer effects. 2. Pharmaceutical compositions containing the peptides according to claim 1 or their pharmaceutically acceptable salts in combination with standard excipients.

Claims (2)

1. Биологически активные пептиды1. Biologically active peptides His-Gly-Val-Ser-Gly-Tyr-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Tyr-Gly-Gln-His-Gly-Val-His-Gly His-Gly-Val-Ser-Gly-Ala-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Ala-Gly-Gln-His-Gly-Val-His-Gly His-Gly-Val-Ser-Gly-Arg-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Arg-Gly-Gln-His-Gly-Val-His-Gly His-Gly-Val-Ser-Gly-Lys-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Lys-Gly-Gln-His-Gly-Val-His-Gly His-Gly-Val-Ser-Gly-Phe-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Phe-Gly-Gln-His-Gly-Val-His-Gly His-Gly-Val-Ser-Gly-Phe(p-OMet)-Gly-Gln-His-Gly-Val-His-GlyHis-Gly-Val-Ser-Gly-Phe (p-OMet) -Gly-Gln-His-Gly-Val-His-Gly His-Gly-Val-Ser-Gly-Phe(p-Cl)-Gly-Gln-His-Gly-Val-His-Gly,His-Gly-Val-Ser-Gly-Phe (p-Cl) -Gly-Gln-His-Gly-Val-His-Gly, обладающие высоким иммуномодулирующем, противовирусным и противораковым действием.possessing high immunomodulatory, antiviral and anti-cancer effects. 2. Фармацевтические композиции, содержащие пептиды по п.1 или их фармацевтически приемлемые соли в сочетании со стандартными вспомогательными веществами. 2. Pharmaceutical compositions containing the peptides according to claim 1 or their pharmaceutically acceptable salts in combination with standard excipients.
RU2013141485/10A 2013-09-10 2013-09-10 Biologically active peptides RU2575069C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2013141485/10A RU2575069C2 (en) 2013-09-10 Biologically active peptides
EA201401290A EA031772B1 (en) 2013-09-10 2014-12-19 Peptides inducing intensified interferon gamma and il-18 formation, and immunomodulatory, antiviral pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013141485/10A RU2575069C2 (en) 2013-09-10 Biologically active peptides

Publications (2)

Publication Number Publication Date
RU2013141485A true RU2013141485A (en) 2015-03-20
RU2575069C2 RU2575069C2 (en) 2016-02-10

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110114060A (en) * 2017-05-05 2019-08-09 长春艾迪尔医用科技发展有限公司 Preparation with bactericidal effect

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110114060A (en) * 2017-05-05 2019-08-09 长春艾迪尔医用科技发展有限公司 Preparation with bactericidal effect
CN110114060B (en) * 2017-05-05 2021-11-02 长春艾迪尔医用科技发展有限公司 Preparation with antibacterial effect

Also Published As

Publication number Publication date
EA031772B1 (en) 2019-02-28
EA201401290A3 (en) 2016-02-29
EA201401290A2 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
CY1122730T1 (en) 1,2,4-TRIAZOLES AS NUCLEAR TRANSPORT MODULATORS AND THEIR USES
CO6501124A2 (en) IMMUNOMODULATING POLYPEPTIDES DERIVED IS THE IL 2 AND ITS THERAPEUTIC USE IN CANCER AND IN CHRONIC INFECTIONS
EA201591524A1 (en) DERIVATIVES 2-AMINOPYRIMIDINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201500857A1 (en) COMBINED VACCINES WITH SYNTHETIC NANO CARRIERS
EA201692254A1 (en) IMMUNOMODULATING PROGENATIVE (IMP) CELLS
CL2013000018A1 (en) Compounds derived from indolizine, their preparation procedure; pharmaceutical composition; and use in the treatment of cancer, among others.
MX2015012743A (en) Pyrazole-amide compound and medicinal uses therefor.
EA201690810A1 (en) SOFT PASTILES CONTAINING EXTRACT TURN
CL2015002897A1 (en) Bace1 inhibitors
MX2015017540A (en) Insulin glargine/lixisenatide fixed ratio formulation.
MY173573A (en) Pyridin-4-yl derivatives
PH12016500985A1 (en) Use of benzimidazole-proline derivatives
WO2014153495A9 (en) Novel stat3 inhibitors
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
PH12015501115A1 (en) Learning and memory improver
PE20220371A1 (en) NOVEL PROCEDURE FOR PURIFICATION OF rHU-GCSF
AR090073A1 (en) N-ETIL-N-PHENYL-1,2-DIHIDRO-4,5-DI-HYDROXI-1-METHYL-2-OXO-3-CHINOLINACARBOXAMIDE, ITS PREPARATION AND USES
EA201500942A1 (en) ANTI-VIRUS INDOLO [2,3-b] HINOXALINE
EA201991265A1 (en) MEDICINAL FORMS WITH DELAYED DELIVERY CONTAINING DIMETHYLFUMARATE
NZ717192A (en) Anti-inflammatory tripeptides
RU2013146452A (en) INJECTION OR INFUSION TRIAZAVIRINE SOLUTION FOR TREATING VIRAL INFECTIONS
RU2013141485A (en) BIOLOGICALLY ACTIVE PEPTIDES
RU2013141484A (en) BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOPHERON-1
RU2010146997A (en) PHARMACEUTICAL COMPOSITION CONTAINING SILDENAFIL AND / OR ALPROSTADIL, MINOXIDIL AND / OR EUFILLIN, TESTOSTERON AND / OR YOCHIMBIN AND LIPOSOMES FOR LOCAL USE
RU2009122296A (en) IMMUNOMETABOLIC ANTHELMINTIC DRUG

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant